News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,385 Results
Type
Article (39625)
Company Profile (247)
Press Release (657513)
Multimedia
Podcasts (47)
Webinars (12)
Section
Business (204129)
Career Advice (2007)
Deals (35413)
Drug Delivery (95)
Drug Development (81030)
Employer Resources (172)
FDA (16170)
Job Trends (14851)
News (345117)
Policy (32525)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2553)
Accelerated approval (5)
Adcomms (20)
Allergies (82)
Alliances (49403)
ALS (86)
Alzheimer's disease (1369)
Antibody-drug conjugate (ADC) (112)
Approvals (16173)
Artificial intelligence (241)
Autoimmune disease (20)
Automation (15)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (104)
Biotechnology (175)
Bladder cancer (62)
Brain cancer (26)
Breast cancer (265)
Cancer (2094)
Cardiovascular disease (167)
Career advice (1674)
Career pathing (29)
CAR-T (143)
Cell therapy (404)
Cervical cancer (19)
Clinical research (65842)
Collaboration (796)
Compensation (514)
Complete response letters (19)
COVID-19 (2582)
CRISPR (37)
C-suite (223)
Cystic fibrosis (100)
Data (2055)
Decentralized trials (2)
Denatured (17)
Depression (39)
Diabetes (258)
Diagnostics (6348)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (118)
Drug pricing (96)
Drug shortages (25)
Duchenne muscular dystrophy (91)
Earnings (86340)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (111905)
Executive appointments (695)
FDA (17363)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (718)
Gene editing (100)
Generative AI (19)
Gene therapy (285)
GLP-1 (699)
Government (4407)
Grass and pollen (4)
Guidances (51)
Healthcare (18811)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (110)
Indications (27)
Infectious disease (2722)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (91)
Interviews (311)
IPO (16494)
IRA (40)
Job creations (3628)
Job search strategy (1422)
Kidney cancer (9)
Labor market (36)
Layoffs (461)
Leadership (16)
Legal (7906)
Liver cancer (72)
Lung cancer (302)
Lymphoma (139)
Machine learning (5)
Management (58)
Manufacturing (283)
MASH (62)
Medical device (13345)
Medtech (13350)
Mergers & acquisitions (19437)
Metabolic disorders (658)
Multiple sclerosis (75)
NASH (16)
Neurodegenerative disease (83)
Neuropsychiatric disorders (24)
Neuroscience (1874)
NextGen: Class of 2025 (6512)
Non-profit (4476)
Northern California (2540)
Now hiring (38)
Obesity (354)
Opinion (204)
Ovarian cancer (73)
Pain (80)
Pancreatic cancer (80)
Parkinson's disease (146)
Partnered (21)
Patents (222)
Patient recruitment (99)
Peanut (46)
People (57212)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20505)
Phase II (28990)
Phase III (21611)
Pipeline (1115)
Policy (130)
Postmarket research (2563)
Preclinical (8676)
Press Release (64)
Prostate cancer (99)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (372)
Real estate (5906)
Recruiting (65)
Regulatory (22208)
Reports (46)
Research institute (2319)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (65)
Series A (124)
Series B (81)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2183)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3572)
State (2)
Stomach cancer (13)
Supply chain (65)
Tariffs (26)
The Weekly (28)
United States (22049)
Vaccines (669)
Venture capitalists (38)
Weight loss (229)
Women's health (34)
Worklife (15)
Date
Today (79)
Last 7 days (431)
Last 30 days (2223)
Last 365 days (32873)
2025 (9282)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37553)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (52)
Alaska (7)
Arizona (229)
Arkansas (13)
Asia (37763)
Australia (6177)
California (5793)
Canada (1943)
China (493)
Colorado (254)
Connecticut (262)
Delaware (136)
Europe (81022)
Florida (862)
Georgia (202)
Idaho (57)
Illinois (513)
India (25)
Indiana (301)
Iowa (10)
Japan (150)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (858)
Massachusetts (4335)
Michigan (215)
Minnesota (379)
Mississippi (2)
Missouri (79)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1665)
New Mexico (28)
New York (1659)
North Carolina (937)
North Dakota (7)
Northern California (2540)
Ohio (194)
Oklahoma (14)
Oregon (33)
Pennsylvania (1305)
Puerto Rico (11)
Rhode Island (31)
South America (1096)
South Carolina (20)
South Dakota (1)
Southern California (2183)
Tennessee (99)
Texas (861)
Utah (172)
Virginia (136)
Washington D.C. (59)
Washington State (530)
West Virginia (3)
Wisconsin (51)
697,385 Results for "duchesnay inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
Duchesnay Inc. is seeking Health Canada approval for a segesterone acetate/ethinyl estradiol contraceptive vaginal system, a new option for women
Duchesnay Inc., member of Duchesnay Pharmaceutical Group (DPG) one of the few anchor companies selected by the Government of Canada for its Global Hypergrowth Project, has recently filed a New Drug Submission (NDS) to Health Canada for its segesterone acetate / ethinyl estradiol slow-release vaginal system developed for contraception control.
November 30, 2023
·
5 min read
Press Releases
Duchesnay Pharmaceutical Group wins 2024 Life Sciences Innovation Award from ADRIQ, the Association for the Development of Research and Innovation of Quebec
November 22, 2024
·
5 min read
Press Releases
Duchesnay Pharmaceutical Group celebrates expansion of its treatment portfolio for nausea and vomiting of pregnancy to 40 countries around the world
October 10, 2024
·
3 min read
Duchesnay announces the launch of Vablys® (dequalinium chloride vaginal tablets), an antiseptic and anti-infective treatment for bacterial vaginosis
Duchesnay Inc, a pharmaceutical company specializing in women’s health and part of Duchesnay Pharmaceutical Group headquartered in Blainville, Quebec, is pleased to announce that it has launched its newest treatment, Vablys ® (dequalinium chloride vaginal tablets).
June 21, 2022
·
4 min read
Slynd® (drospirenone), a new progestin-only contraceptive pill from Duchesnay which offers a 24-hour safe window for a missed pill
A new progestin-only contraceptive pill is now available to Canadians from Duchesnay Inc., a pharmaceutical company specializing in women’s health and part of the Duchesnay Pharmaceutical Group headquartered in Blainville, Quebec.
May 17, 2022
·
4 min read
Press Releases
Slynd is now available to 95% of the Canadian population under public insurance plans
February 28, 2025
·
5 min read
Press Releases
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
April 14, 2025
·
2 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc.to Participate in an H.C. Wainwright @ Home Fireside Discussion on Tuesday, April 22, 2025
April 21, 2025
·
4 min read
Press Releases
FDA Classifies Q’Apel Medical Inc.'s Worldwide Medical Device Recall and Discontinuation of its 072 Aspiration System (Hippo) as Class I
April 18, 2025
·
4 min read
1 of 69,739
Next
